Wrist mass - Large Biopsy 3-6 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histopathology of wrist lesion.

₹666₹951

30% OFF

Wrist Mass - Large Biopsy 3-6 cm

Why is it done?
- Tissue diagnosis of palpable wrist masses measuring 3-6 cm in size
- Determines benign versus malignant nature of the lesion
- Characterizes mass type when imaging (ultrasound, MRI, or CT) shows indeterminate findings
- Investigates persistent wrist swelling with unclear etiology
- Guides treatment planning and determines surgical versus conservative management
- Performed when needle biopsy is inconclusive or nondiagnostic
- Timing: Usually performed after imaging studies and when clinical concern warrants definitive diagnosis
Normal Range
- Normal Result: Benign pathology with specific diagnosis (e.g., ganglion cyst, lipoma, hemangioma, fibromatosis)
- Abnormal Result: Malignant pathology including sarcoma, lymphoma, or metastatic disease
- Units of Measurement: Histopathological diagnosis and grade reported as descriptive text with associated tumor staging when applicable
- Interpretation Context: Normal indicates benign process with generally favorable prognosis; abnormal indicates need for oncologic management and staging studies
Interpretation
- Benign Diagnoses:
- Ganglion cyst: Most common benign wrist mass; fluid-filled; generally asymptomatic or mildly symptomatic
- Lipoma: Benign fatty tumor; slow-growing; painless
- Giant cell tumor of tendon sheath: Benign but locally aggressive; may cause functional impairment
- Hemangioma: Benign vascular lesion; may be painful or symptomatic
- Palmar/plantar fibromatosis: Benign fibrous proliferation; may limit hand function
- Malignant Diagnoses:
- Soft tissue sarcoma: High-grade or low-grade; includes synovial sarcoma, leiomyosarcoma, or fibrosarcoma variants
- Lymphoma: Primary cutaneous or systemic; presents as mass or swelling
- Metastatic disease: Secondary malignancy from distant primary tumor
- Factors Affecting Interpretation:
- Grade of lesion (if malignant): Low-grade tumors have better prognosis than high-grade
- Margins: Clear margins suggest benign or completely excised lesion; infiltrative margins indicate more aggressive disease
- Mitotic rate and cellular atypia: Higher rates correlate with malignancy and worse prognosis
- Specimen adequacy: Large biopsies provide more representative tissue than smaller samples
- Immunohistochemical staining: May be performed to confirm diagnosis and determine cell origin
Associated Organs
- Primary Structures Involved:
- Wrist soft tissues: Skin, subcutaneous fat, fascia, muscles, and tendons
- Carpal bones: Bones of the wrist (scaphoid, lunate, triquetrum, pisiform, trapezium, trapezoid, capitate, hamate)
- Joint capsule and synovium: Connective tissues surrounding the wrist articulation
- Lymph nodes: Regional lymph nodes may be involved in lymphoproliferative disorders
- Conditions Commonly Associated with Abnormal Results:
- Soft tissue sarcomas: Leiomyosarcoma, synovial sarcoma, fibrosarcoma, rhabdomyosarcoma
- Lymphomas: Hodgkin lymphoma, diffuse large B-cell lymphoma, cutaneous lymphomas
- Metastatic tumors: Secondary deposits from lung, breast, melanoma, or other primaries
- Bone tumors: Osteosarcoma, chondrosarcoma, or primary bone lymphoma involving carpal bones
- Potential Complications or Risks Associated with Abnormal Results:
- Local invasion: Malignant lesions may invade adjacent structures (tendons, nerves, vessels)
- Loss of hand function: Large or invasive lesions may compromise wrist/hand mobility and strength
- Vascular compromise: Lesions pressing on radial or ulnar arteries may cause ischemia
- Nerve compression: Masses may compress median or ulnar nerves causing sensory/motor deficits
- Systemic spread: Malignant lesions carry risk of regional/distant metastases
Follow-up Tests
- If Benign Diagnosis Confirmed:
- Clinical follow-up: Physical examination at 3-6 months to assess for recurrence or symptom progression
- Ultrasound or MRI: Repeat imaging at 6-12 months for lesions with potential for recurrence
- Surgical consultation: If lesion is causing functional impairment or cosmetic concern
- If Malignant Diagnosis Confirmed:
- Staging studies: CT or MRI of chest, abdomen, and pelvis to evaluate for metastatic disease
- PET-CT scan: May be indicated for high-grade sarcomas to detect systemic involvement
- Oncology consultation: Referral to medical or surgical oncologist for treatment planning
- Molecular/genetic testing: May include gene amplification studies, translocation analysis (e.g., t(X;18) for synovial sarcoma)
- Advanced imaging: High-resolution MRI for surgical planning and assessment of tissue planes
- Surgical resection: Wide excision with adequate margins is typically recommended
- Chemotherapy or radiation: May be indicated based on grade, stage, and histologic type
- Complementary Tests:
- Flow cytometry: May be useful if lymphoproliferative disorder is suspected
- Cytogenetic analysis: For sarcomas to identify specific translocation patterns affecting prognosis and treatment
- Laboratory studies: CBC, comprehensive metabolic panel, and LDH baseline for malignant lesions
- Monitoring Frequency:
- Benign lesions: Clinical examination every 6-12 months if untreated
- Malignant lesions: Imaging and clinical assessment every 3 months for first 2 years, then every 6 months for years 3-5, then annual surveillance indefinitely
Fasting Required?
- Fasting: No
- Fasting is not required for this biopsy procedure. Patients may eat and drink normally before the procedure.
- Patient Preparation and Special Instructions:
- Obtain informed consent: Discuss procedure risks, benefits, and alternatives with patient
- Discontinue anticoagulation: Stop warfarin 3-5 days prior; hold aspirin 3-5 days if possible (discuss with ordering physician); stop direct oral anticoagulants 24-48 hours prior based on renal function
- Medication review: Continue all other medications unless specifically instructed otherwise by the physician
- Skin preparation: Wash wrist area thoroughly with soap and water the morning of procedure; do not apply lotions, deodorants, or other topical products
- Avoid NSAIDs: Do not take ibuprofen, naproxen, or other NSAIDs for 3-5 days before procedure (may increase bleeding risk)
- Arrange transportation: Patient should have a responsible adult available for transportation if local anesthesia or sedation is used
- Imaging review: Bring prior imaging studies (ultrasound, MRI, CT) to help guide biopsy needle placement
- Anesthesia type: Procedure typically performed under local anesthesia ± sedation; general anesthesia may be used if sedation is preferred
- Post-procedure care: Keep bandage clean and dry for 24-48 hours; avoid strenuous wrist activity for 3-5 days; take acetaminophen for mild pain (avoid NSAIDs)
- Return precautions: Report fever, increasing swelling, redness, drainage, or severe pain to physician

How our test process works!